Prognostic value of Ki67 index in gastrointestinal stromal tumors.

Abstract

Ki67 index is an effective complementation of modified NIH criteria in predicting the prognosis of GISTs, and Ki67 index>8% may act as an unfavorable factor for imatinib adjuvant therapy.